Studies related to Heart Rate and Coenzyme Q10

Impact Of Oral Ubiquinol On Blood Oxidative Stress And Exercise Performance

Effect None
Values BPM. Mean and SEM. At 8 minutes in treadmill test: Placebo: 122.2 ± 5.7 Intervention: 119.9 ± 6.4 At 14 minutes: Placebo: 147.1 ± 5.0 intervention 148.2 ± 6.5. Cycling: Placebo: 156.4 ± 3.2 Coq10: 155.6 ± 3.6
Trial Design Randomized trial
Trial Length 2-4 Weeks
Number of Subjects 15
Sex Both Genders
Body Types Trained
Notes for this study:
In a randomized, double-blind, crossover trial, 15 exercise-trained participants took 300 mg of ubiquinol daily and placebo for four weeks, separated by a 3-week washout period. Participants maintained their exercise routines and were subjected to graded exercise tests on treadmills and cycle sprint tests on a cycle ergometer.

There were no statistically significant differences in heart rate, perceived exertion, or time on the treadmill test, and no statistically significant differences in heart rate, perceived exertion, peak power, mean power, or total work on the cycling test. There were no statistically significant differences in malondialdehyde, hydrogen peroxide, or total cholesterol at rest, nor were there statistically significant differences in malondialdehyde, hydrogen peroxide, or lactate during the exercise tests.
Funding issues for this study:
"Financial support for this work was provided by Kaneka Nutrients (Pasdena, TX). The investigators and the University of Memphis have no direct or indirect interest in the tested product (Kaneka QH) or in Kaneka Nutrients."